Concepedia

Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin

Naif K. Binsaleh, Catherine A. Wigley, Kathryn A. Whitehead, Michelle van Rensburg, Jóhannes Reynisson, Lisa I. Pilkington, David Barker, Sarah Jones, Nina Dempsey‐Hibbert

European Journal of Medicinal Chemistry · 2017 · 38 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

inhibitors for improved treatment for patients.

References

33

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine · 2009 · 7.1K citations · Full text

, , +14

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine · 2007 · 6.7K citations · Full text

, , +1

Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.

Sanford J. Shattil, James A. Hoxie, Michael Cunningham et al. · Journal of Biological Chemistry · 1985 · 954 citations · Full text

, , +17

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

Jean‐Sébastien Hulot · Blood · 2006 · 929 citations · Full text

, , +17

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

Matthew T. Roe, Paul W. Armstrong, Keith A.A. Fox et al. · New England Journal of Medicine · 2012 · 871 citations · Full text

, , +14